Home About Us Products Range Contact Us Enquiry
Parth Web Solutions Pvt LtdParth Web Solutions Pvt Ltd

Products Range

Showroom

View all our products / services as a slide show.

play now


DEPRESSION CARE

Share: FacebookTwitterStumble
Providing you the best range of DEPRESSION CARE such as CYMBALTA-60 (Duloxetine hydrochloride-60) Drop shipper and ESKALITH -450 CR Controlled-Release Drop shipper with effective & timely delivery.


CYMBALTA-60 (Duloxetine hydrochloride-60) Drop shipper

Duloxetine is used to treat major depression and also used to relieve nerve pain (peripheral neuropathy) in diabetics. This medication works by restoring the balance of two kinds of natural substances (neurotransmitters known as serotonin and norepinephrine) in the brain, thereby improving mood and feelings of well-being.

CYMBALTA-60 (Duloxetine hydrochloride-60) Drop shipper

Send Enquiry

ESKALITH -450 CR Controlled-Release Drop shipper

ESKALITH -450 CR Controlled-Release Drop shipper

Eskalith
Indications & Dosage and INDICATIONS
ESKALITH (lithium carbonate) is indicated in the treatment of manic episodes of manic-depressive illness. Maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania.

Send Enquiry

Contact Us
Mr. Brijesh Shah (Director)
Lake Town, Bibwewadi, Mahalaxmi Nagar
Pune, Maharashtra - 411 037, India
Telephone:  +(91)-(20)-24204650

Contact via E-mail

Contact via Mobile

Contact via SMS

Home  |  About Us  |  Products Range  |  Media Gallery   |  Site Map  |  Distributor Enquiry Form  |  Contact Us  |  Enquiry

Member IndiaMART.com © Parth Web Solutions Pvt Ltd. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Business Enquiry Form


Add More Products / Services

(* represents compulsory fields )

*Describe Your Requirements in Detail
Please Fill Your Contact Information
*Contact Person:
*Email:
Company:
Street Address:
*Country:
*Telephone:
Mobile:
Website:
*Enter the code:

Send me a copy of this enquiry